As part of the globally active Fresenius Group, headquartered in Bad Homburg, Germany. Fresenius Kabi corporate philosophy is caring for life. Our generics and biosimilars play a crucial role in ensuring access to medicines with 15,000 employees in Europe alone and our production facilities in France, Germany, Austria, Italy, Sweden, and other countries, we contribute to Europe's health sovereignty.
FK
Fresenius Kabi
Company · Germany · EU Transparency Register 130305227617-65not in register snapshot
This register number is the organization’s own declaration on its submission. It is not in the 20 Oct 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.
2
positions filed
in the 673 files tracked
2
legislative files
of 673 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Fresenius in PolicySpeak: request access →
Work at Fresenius Kabi? so we know who speaks for it.
Their record over time
Fresenius Kabi filed 2 positions between 8 Nov 2023 and 27 Feb 2025, across 2 of the 673 legislative files tracked here, attaching a full position paper 1 time.
2023 · 1 filed2025 · 1 filed
What they argued
The Critical Medicines Act must lead to a resilient, competitive, and sustainable off-patent pharmaceutical industry. It must ensure secure supply chains, reward investment, and strengthen Europes autonomy in critical medicines.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Fresenius Kabi next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 66.
Is this your organization?
Everything on this page comes from Fresenius Kabi’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.